CN105535016A - New use of nitrate in prevention and treatment of malignant tumors - Google Patents

New use of nitrate in prevention and treatment of malignant tumors Download PDF

Info

Publication number
CN105535016A
CN105535016A CN201510634364.XA CN201510634364A CN105535016A CN 105535016 A CN105535016 A CN 105535016A CN 201510634364 A CN201510634364 A CN 201510634364A CN 105535016 A CN105535016 A CN 105535016A
Authority
CN
China
Prior art keywords
nitrate
oral
carcinoma
oral carcinoma
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510634364.XA
Other languages
Chinese (zh)
Inventor
王松灵
庞宝兴
曲兴民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510634364.XA priority Critical patent/CN105535016A/en
Priority to PCT/CN2015/098313 priority patent/WO2017054336A1/en
Publication of CN105535016A publication Critical patent/CN105535016A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

In the invention, a human oral squamous cell carcinoma cell line CAL27 is selected as a research object, an oral carcinoma nude mouse transplanted tumor model is established, sodium nitrate drinking-water (0.5mmol/Kg b.w.) is given, an animal is killed 1 month later, and a result shows that nitrate diet obviously alleviates rapid increase of the volume of oral carcinoma transplanted tumors, and application of the nitrate makes the body weight of the nude mouse have no obvious change. Additionally, sodium nitrate is added to oral carcinoma CAL27 cells in vitro, and a result shows that high concentrate nitrate can obviously inhibit proliferation of tumor cells, promotes apoptosis and obviously inhibits mitigation of the tumor cells. The inhibition effect of nitrate on the oral carcinoma, found for the first time, shows the importance of the nitrate in the prevention and treatment of the oral carcinoma and even whole body tumors.

Description

Nitrate prevents and treats the novelty teabag of malignant tumor
Technical field
The present invention relates to nitrate and the novelty teabag of related preparations in prevention and therapy malignant tumor thereof, belong to pharmaceutical sanitary field.
Background technology
Nitrate is a kind of inorganic matter that nature extensively exists, and plant can absorb and utilize nitrate in soil with nitrogen element required in supplying.Nitrate major part in food derives from green vegetables.Traditional viewpoint is thought, NO3-N and NO2-N class in diet has potential carcinogenic tendency, and people recognize subsequently, and nitrite only has with amine substance combination formation inferior ammonium nitrate compounds, and when reaching certain concentration, just can show carcinogenesis.At present, nitric oxide (the NitricOxide that nitrate and downstream passages thereof produce, NO) reducing blood pressure, regulate antiotasis, the definite effect bearing the aspects such as nerve signal transmission of signal molecule and immunomodulating has reached common recognition, this loading by exogenous nitrate, increases the expression of nitrate and downstream passages NO etc. thereof in body, for the control of some disease opens up a new way.
Oral squamous cell carcinoma is the modal malignant tumor of incidence, sickness rate has and increases trend in recent years, clinically because tumor growth is fast, wellability strong, normal early stage Cervical Lymph Node Metastasis occurs, often take the general treatment measures of operation, radiotherapy, chemotherapy and targeted therapy etc., prognosis is poor.
At present, research or the application of patent report nitrate diet in prevention and therapy tumor is not yet had.
Summary of the invention
The present inventor find, nitrate diet obviously slows down the quick growth of oral cancer transplanted tumor in nude mice, and the application of nitrate to nude mice body weight without significant change.
We find, adopt the diet being rich in nitrate transplantation tumor to increase fast, the nitrate concentration of its every daily ingestion is 0.5mmol/Kg.
We find, nitrate obviously can suppress propagation and the migration of cancer cell of oral cavity, promote the apoptosis of cancer cell of oral cavity.
Discovery of the present invention can be applicable to prevention, treatment oral cancer, also has reference to the treatment of general tumour.
Accompanying drawing explanation
Fig. 1 is the impact of nitrate diet on oral cancer CAL27 cell transplanted tumor in nude mice volume.Result shows that nitrate diet obviously slows down the quick growth of oral cancer transplanted tumor volume.
Fig. 2 is that nitrate diet transplants the impact of nude mice body weight to oral cancer CAL27.Result shows the application of nitrate to nude mice body weight without significant change.
Fig. 3 is the impact of nitrate on oral cancer CAL27 cellular morphology.Under result shows inverted microscope, cellular control unit adherent growth, cell is fusiformis or polygon, and endochylema enriches, and grows vigorous, and flanking cell growth is merged in flakes.After adding the Chile saltpeter of 100mM, CAL27 cell starts to diminish, become circle, and refractivity strengthens, and cell attachment reduces, and presents typical apoptosis form, the morphological change such as the coagulation of visible stain matter, karyopycnosis, karyorrhexis under mirror.
Fig. 4 is the impact of nitrate on oral cancer CAL27 cell proliferation.Result shows the propagation of the obvious inhibition tumor cell of high concentration nitrate (more than 30mM concentration).
Fig. 5 is the impact of nitrate on oral cancer CAL27 apoptosis.Result shows that the nitrate of 100mM obviously promotes apoptosis of tumor cells.
Fig. 6 is the impact of nitrate on oral cancer CAL27 cell migration.Result shows that 50mM obviously suppresses the migration of cancer cell of oral cavity.
Detailed description of the invention
1, the foundation of oral cancer Nude Mouse Model
Select 4 week age Female nude mice to be laboratory animal, cellar culture human mouth squamous cell carcinoma system CAL27, by 2.5 × 10 7/ ml concentration, only injects into nude mice right hind groin subcutaneous with 0.2ml/.Each group of process factor is given when tumor body enters the quick rise period.
2, nitrate drinking water administration and transplanted tumor in nude mice are observed
Experiment is divided into matched group and Nitrate group, often organizes 10.Nitrate group gives Chile saltpeter drinking-water, and concentration is 2.5mmol/L, and the nitrate content of every every daily ingestion of rat is about 0.5mmol/Kgb.w., and continuous nitrate is drunk water 1 month, matched group normal water.Periodic logging transplanted tumor tumor volume and nude mice body weight.
3, the impact of nitrate oral cancer cell propagation, apoptosis and migration
(1) CCK8 detects propagation
100 μ l cell suspension are inoculated in 96 orifice plates, by culture plate in incubator preculture 24 hours (at 37 DEG C, under the condition of 5%CO2), subsequently culture plate is hatched 72 hours at incubator, the culture medium 100 μ l that every hole renews, and 10 μ lCCK-8 solution are added to every hole.Be determined at the absorbance at 450nm place by microplate reader after 2 hours.
(2) Flow cytometry apoptosis
1) cell inoculates 6 orifice plates, after drug treating, with the collected by trypsinisation not containing EDTA;
2) PBS washed cell 2 times are used, centrifugal, collecting cell;
3) the BindingBuffer suspension cell of 500 μ l is added;
4), after adding 5 μ lAnnexinV-FITC mixings, 5 μ lPropidiumIodide are added, mixing;
5) room temperature, lucifuge, reaction 5-15min;
6) in 1h, flow cytometer detects apoptosis situation.
(3) scarification detects cell migration
Cell is cultivated respectively in 6 orifice plates, Growth of Cells inhales sample rifle head by cell cut to converging rear use 200 μ l sterilizing completely, 1 × PBS washes 1 time, continue to cultivate 6h by the RPMI1640 culture medium containing 10% new-born calf serum, the RPMI1640 culture medium that cellular-restoring is used instead containing 0.5% hyclone again continues to cultivate, observe under inverted microscope machinery scratch after (0h) each cut position taking a picture at once, after 24h, again under inverted microscope, observe mechanical mark and take a picture.
4, statistical method
Adopt SPSS17.0 statistics software to carry out statistical analysis, many Sets of Measurement Datas compare employing ANOVA and analyze, and P < 0.05 has statistical significance.

Claims (3)

1. nitrate is used for the prevention and therapy of oral cancer and general tumour.
2. application according to claim 1, is characterized in that, described nitrate is selected from Chile saltpeter, potassium nitrate, lime nitrate and combination thereof, comprises the food and extract that are rich in nitrate.
3. the application according to claim 1-2, is characterized in that, the dosage form of the medicine of described anti-curing oncoma is tablet, capsule, pill, injection, syrup, oral liquid, granule or patch.
CN201510634364.XA 2015-09-30 2015-09-30 New use of nitrate in prevention and treatment of malignant tumors Pending CN105535016A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201510634364.XA CN105535016A (en) 2015-09-30 2015-09-30 New use of nitrate in prevention and treatment of malignant tumors
PCT/CN2015/098313 WO2017054336A1 (en) 2015-09-30 2015-12-22 Application of nitrate in preparation of drug preventing or treating tumours

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510634364.XA CN105535016A (en) 2015-09-30 2015-09-30 New use of nitrate in prevention and treatment of malignant tumors

Publications (1)

Publication Number Publication Date
CN105535016A true CN105535016A (en) 2016-05-04

Family

ID=55814942

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510634364.XA Pending CN105535016A (en) 2015-09-30 2015-09-30 New use of nitrate in prevention and treatment of malignant tumors

Country Status (2)

Country Link
CN (1) CN105535016A (en)
WO (1) WO2017054336A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110327367A (en) * 2019-06-21 2019-10-15 北京爱希国际贸易有限公司 Composition, preparation method, preparation containing nitrate and vitamin and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120002C (en) * 1999-10-09 2003-09-03 兰州凯瑞中药科技开发有限公司 Application of ammonium nilrate in pharmaceutical industry, food and health-care product

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
QIANG JIA ET AL: "NO donors with anticancer activity", 《EXPERT OPINION ON THERAPEUTIC PATENTS》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110327367A (en) * 2019-06-21 2019-10-15 北京爱希国际贸易有限公司 Composition, preparation method, preparation containing nitrate and vitamin and application thereof
WO2020253835A1 (en) * 2019-06-21 2020-12-24 爱希(北京)国际咨询有限公司 Nitrate and vitamin-containing composition, preparation method therefor, formulation thereof and use thereof

Also Published As

Publication number Publication date
WO2017054336A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
De Brabander et al. The effects of methyl [5-(2-thienylcarbonyl)-1 H-benzimidazol-2-yl] carbamate,(R 17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro
CN101485655A (en) Application of dihydromyricetin in preparing medicament for preventing and treating adverse reaction of tumor chemoradiotherapy
CN105878289A (en) Periplaneta americana preparation and applications thereof in preparing medicines for treating gastric cancer
CN103230401B (en) The application of Tripterygium wilfordii lactone ketone in anti-angiogenic drugs
Hernandez-Unzueta et al. Ocoxin oral solution exerts an antitumoral effect in pancreatic cancer and reduces the stromal-mediated chemoresistance
CN105535016A (en) New use of nitrate in prevention and treatment of malignant tumors
JP5696191B2 (en) Anticancer stem cell agent
CN100443080C (en) Medicinal composition for preventing and treating cancer diseases
CN102125698A (en) Method for establishing mouse transplanting tumor model with normal immunologic function
CN107569485A (en) A kind of compound preparation for treating BRAF inhibitor drug-resistant type melanomas
CN106974908A (en) Pharmaceutical composition and purposes containing hdac inhibitor and IRE1 inhibitor
CN106075453A (en) A kind of anti-tumor medicinal preparation combination
CN109420167B (en) Combined medicine for treating tumor
CN108014105B (en) Application of YD1701 in preparation of medicine for treating ALDH1A3 high expression tumor
CN113329745A (en) Pharmaceutical composition for effectively resisting malignant tumor and application thereof
CN115400216A (en) Pharmaceutical composition for thyroid undifferentiated carcinoma and application
CN102688228B (en) Pharmaceutical composition containing apigenin, apigenin derivative, rubescensin and rubescensin derivative, and application thereof
KR20150066224A (en) Composition for suppression of cancer metastasis containing YCG063
CN109528731A (en) Pharmaceutical composition and its application with co-action for treating Huppert&#39;s disease
CN106075454A (en) A kind of anti-tumor medicinal preparation combination
CN103990126A (en) Synergic pharmaceutical composition treating tumors
KR102032929B1 (en) Radiation sensitizer composition comprising micro RNA-30a and RNA-30b
CN105999245B (en) Purposes of the pharmaceutical composition containing ulinastatin in preparation treatment gall-bladder cancer drug
CN109419792A (en) It is a kind of to treat gastric cancer compound
CN104784179A (en) Application of tipranavir to breast cancer-resistant drug and breast cancer-resistant drug

Legal Events

Date Code Title Description
DD01 Delivery of document by public notice

Addressee: Xu Xiaomin

Document name: Notification of Passing Examination on Formalities

C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160504